Mucosal immunopathogenesis of Francisella tularensis

Dennis W. Metzger, Chandra Shekhar Bakshi, Girish Soorapp Kirimanjeswara

Research output: Chapter in Book/Report/Conference proceedingChapter

49 Citations (Scopus)

Abstract

Respiratory infection with Francisella tularensis is the deadliest form of disease and represents the most likely route to be used by bioterrorists. Although mucosal surfaces represent the first line of defense against respiratory tularemia, and in fact, against the great majority of human pathogens, little is known about protective immunity at these sites. The objective of this chapter is to review recent data examining the importance of various pulmonary immune mechanisms in defense against F. tularensis infection and to evaluate potential strategies for induction of protective lung immunity. Aerosol and intranasal mouse infection models have yielded essentially equivalent results and have implicated an important role for Th1-type immune responses in protection, including IFN-γ, TNF-α, and IL-12. The cells responsible for protection in the lung are not well-characterized but NK cells are an early target for activation after infection although it appears that CD8 T cells might be most critical for host resistance. In addition, it is becoming increasingly clear that antibodies can provide prophylactic and therapeutic protection against pulmonary infection but only in the presence of active cell-mediated immunity. In fact, in vitro exposure of resting macrophages to antibody-coated bacteria in the absence of IFN-γ can actually enhance infection. Although various immune mechanisms can be shown to be important for protection against attenuated strains such as LVS, the real challenge for the future is to design efficacious approaches to prevent disease by highly virulent strains such as SchuS4.

Original languageEnglish (US)
Title of host publicationFrancisella Tularensis
Subtitle of host publicationBiology, Pathogenicity, Epidemiology, and Biodefense
PublisherBlackwell Publishing Inc.
Pages266-283
Number of pages18
ISBN (Print)1573316911, 9781573316910
DOIs
StatePublished - Jan 1 2007

Publication series

NameAnnals of the New York Academy of Sciences
Volume1105
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

Fingerprint

Francisella tularensis
Tularemia
Lung
T-cells
Antibodies
Macrophages
Pathogens
Interleukin-12
Infection
Aerosols
Immunity
Bacteria
Chemical activation
Active Immunity
Cytoprotection
Cellular Immunity
Natural Killer Cells
Respiratory Tract Infections
T-Lymphocytes
Cells

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Metzger, D. W., Bakshi, C. S., & Kirimanjeswara, G. S. (2007). Mucosal immunopathogenesis of Francisella tularensis. In Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense (pp. 266-283). (Annals of the New York Academy of Sciences; Vol. 1105). Blackwell Publishing Inc.. https://doi.org/10.1196/annals.1409.007
Metzger, Dennis W. ; Bakshi, Chandra Shekhar ; Kirimanjeswara, Girish Soorapp. / Mucosal immunopathogenesis of Francisella tularensis. Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense. Blackwell Publishing Inc., 2007. pp. 266-283 (Annals of the New York Academy of Sciences).
@inbook{ef820c82cf3f418eac3096c17d82e23d,
title = "Mucosal immunopathogenesis of Francisella tularensis",
abstract = "Respiratory infection with Francisella tularensis is the deadliest form of disease and represents the most likely route to be used by bioterrorists. Although mucosal surfaces represent the first line of defense against respiratory tularemia, and in fact, against the great majority of human pathogens, little is known about protective immunity at these sites. The objective of this chapter is to review recent data examining the importance of various pulmonary immune mechanisms in defense against F. tularensis infection and to evaluate potential strategies for induction of protective lung immunity. Aerosol and intranasal mouse infection models have yielded essentially equivalent results and have implicated an important role for Th1-type immune responses in protection, including IFN-γ, TNF-α, and IL-12. The cells responsible for protection in the lung are not well-characterized but NK cells are an early target for activation after infection although it appears that CD8 T cells might be most critical for host resistance. In addition, it is becoming increasingly clear that antibodies can provide prophylactic and therapeutic protection against pulmonary infection but only in the presence of active cell-mediated immunity. In fact, in vitro exposure of resting macrophages to antibody-coated bacteria in the absence of IFN-γ can actually enhance infection. Although various immune mechanisms can be shown to be important for protection against attenuated strains such as LVS, the real challenge for the future is to design efficacious approaches to prevent disease by highly virulent strains such as SchuS4.",
author = "Metzger, {Dennis W.} and Bakshi, {Chandra Shekhar} and Kirimanjeswara, {Girish Soorapp}",
year = "2007",
month = "1",
day = "1",
doi = "10.1196/annals.1409.007",
language = "English (US)",
isbn = "1573316911",
series = "Annals of the New York Academy of Sciences",
publisher = "Blackwell Publishing Inc.",
pages = "266--283",
booktitle = "Francisella Tularensis",

}

Metzger, DW, Bakshi, CS & Kirimanjeswara, GS 2007, Mucosal immunopathogenesis of Francisella tularensis. in Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense. Annals of the New York Academy of Sciences, vol. 1105, Blackwell Publishing Inc., pp. 266-283. https://doi.org/10.1196/annals.1409.007

Mucosal immunopathogenesis of Francisella tularensis. / Metzger, Dennis W.; Bakshi, Chandra Shekhar; Kirimanjeswara, Girish Soorapp.

Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense. Blackwell Publishing Inc., 2007. p. 266-283 (Annals of the New York Academy of Sciences; Vol. 1105).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Mucosal immunopathogenesis of Francisella tularensis

AU - Metzger, Dennis W.

AU - Bakshi, Chandra Shekhar

AU - Kirimanjeswara, Girish Soorapp

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Respiratory infection with Francisella tularensis is the deadliest form of disease and represents the most likely route to be used by bioterrorists. Although mucosal surfaces represent the first line of defense against respiratory tularemia, and in fact, against the great majority of human pathogens, little is known about protective immunity at these sites. The objective of this chapter is to review recent data examining the importance of various pulmonary immune mechanisms in defense against F. tularensis infection and to evaluate potential strategies for induction of protective lung immunity. Aerosol and intranasal mouse infection models have yielded essentially equivalent results and have implicated an important role for Th1-type immune responses in protection, including IFN-γ, TNF-α, and IL-12. The cells responsible for protection in the lung are not well-characterized but NK cells are an early target for activation after infection although it appears that CD8 T cells might be most critical for host resistance. In addition, it is becoming increasingly clear that antibodies can provide prophylactic and therapeutic protection against pulmonary infection but only in the presence of active cell-mediated immunity. In fact, in vitro exposure of resting macrophages to antibody-coated bacteria in the absence of IFN-γ can actually enhance infection. Although various immune mechanisms can be shown to be important for protection against attenuated strains such as LVS, the real challenge for the future is to design efficacious approaches to prevent disease by highly virulent strains such as SchuS4.

AB - Respiratory infection with Francisella tularensis is the deadliest form of disease and represents the most likely route to be used by bioterrorists. Although mucosal surfaces represent the first line of defense against respiratory tularemia, and in fact, against the great majority of human pathogens, little is known about protective immunity at these sites. The objective of this chapter is to review recent data examining the importance of various pulmonary immune mechanisms in defense against F. tularensis infection and to evaluate potential strategies for induction of protective lung immunity. Aerosol and intranasal mouse infection models have yielded essentially equivalent results and have implicated an important role for Th1-type immune responses in protection, including IFN-γ, TNF-α, and IL-12. The cells responsible for protection in the lung are not well-characterized but NK cells are an early target for activation after infection although it appears that CD8 T cells might be most critical for host resistance. In addition, it is becoming increasingly clear that antibodies can provide prophylactic and therapeutic protection against pulmonary infection but only in the presence of active cell-mediated immunity. In fact, in vitro exposure of resting macrophages to antibody-coated bacteria in the absence of IFN-γ can actually enhance infection. Although various immune mechanisms can be shown to be important for protection against attenuated strains such as LVS, the real challenge for the future is to design efficacious approaches to prevent disease by highly virulent strains such as SchuS4.

UR - http://www.scopus.com/inward/record.url?scp=34548486031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548486031&partnerID=8YFLogxK

U2 - 10.1196/annals.1409.007

DO - 10.1196/annals.1409.007

M3 - Chapter

C2 - 17395728

AN - SCOPUS:34548486031

SN - 1573316911

SN - 9781573316910

T3 - Annals of the New York Academy of Sciences

SP - 266

EP - 283

BT - Francisella Tularensis

PB - Blackwell Publishing Inc.

ER -

Metzger DW, Bakshi CS, Kirimanjeswara GS. Mucosal immunopathogenesis of Francisella tularensis. In Francisella Tularensis: Biology, Pathogenicity, Epidemiology, and Biodefense. Blackwell Publishing Inc. 2007. p. 266-283. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1409.007